Related Experiment Video
Updated: May 18, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
In search of preclinical robustness
Ian S Peers1, Peter R Ceuppens, Chris Harbron
1AstraZeneca 13F41 Mereside, Alderley Park, Macclesfield SK10 4TG, UK. Ian.Peers@astrazeneca.com
Systematic involvement of statisticians in early drug research can improve success rates. Addressing current weaknesses in preclinical studies is crucial for effective drug discovery and development.
Area of Science:
- Pharmacology
- Biostatistics
- Drug Development
Background:
- Preclinical research is foundational for drug discovery.
- Current preclinical methodologies have inherent weaknesses.
- These weaknesses impact the success of drug development.
Purpose of the Study:
- To highlight the importance of statistical input in preclinical research.
- To propose statisticians' engagement as a solution to identified weaknesses.
Main Methods:
- Review of current preclinical research practices.
- Analysis of common pitfalls in early-stage drug development.
- Identification of areas where statistical expertise can be applied.
Main Results:
- Preclinical studies often lack rigorous statistical design.
- Inadequate statistical analysis leads to unreliable results.
- Early statistical input can enhance data interpretation and validity.
Conclusions:
- Systematic engagement of statisticians is vital for robust preclinical research.
- This integration can mitigate risks and improve the efficiency of drug discovery.
- Strengthening preclinical phases ensures a higher likelihood of successful drug development.
Related Concept Videos
Preclinical Development: Overview
In vitro Mutagenesis
In-vitro Mutagenesis
Drug Discovery: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
In Vitro Drug Release Testing: Overview, Development and Validation
